Cargando…

Plant-based vaccines against viruses

Plant-made or “biofarmed” viral vaccines are some of the earliest products of the technology of plant molecular farming, and remain some of the brightest prospects for the success of this field. Proofs of principle and of efficacy exist for many candidate viral veterinary vaccines; the use of plant-...

Descripción completa

Detalles Bibliográficos
Autor principal: Rybicki, Edward P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4264547/
https://www.ncbi.nlm.nih.gov/pubmed/25465382
http://dx.doi.org/10.1186/s12985-014-0205-0
_version_ 1782348762218233856
author Rybicki, Edward P
author_facet Rybicki, Edward P
author_sort Rybicki, Edward P
collection PubMed
description Plant-made or “biofarmed” viral vaccines are some of the earliest products of the technology of plant molecular farming, and remain some of the brightest prospects for the success of this field. Proofs of principle and of efficacy exist for many candidate viral veterinary vaccines; the use of plant-made viral antigens and of monoclonal antibodies for therapy of animal and even human viral disease is also well established. This review explores some of the more prominent recent advances in the biofarming of viral vaccines and therapies, including the recent use of ZMapp for Ebolavirus infection, and explores some possible future applications of the technology.
format Online
Article
Text
id pubmed-4264547
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42645472014-12-13 Plant-based vaccines against viruses Rybicki, Edward P Virol J Review Plant-made or “biofarmed” viral vaccines are some of the earliest products of the technology of plant molecular farming, and remain some of the brightest prospects for the success of this field. Proofs of principle and of efficacy exist for many candidate viral veterinary vaccines; the use of plant-made viral antigens and of monoclonal antibodies for therapy of animal and even human viral disease is also well established. This review explores some of the more prominent recent advances in the biofarming of viral vaccines and therapies, including the recent use of ZMapp for Ebolavirus infection, and explores some possible future applications of the technology. BioMed Central 2014-12-03 /pmc/articles/PMC4264547/ /pubmed/25465382 http://dx.doi.org/10.1186/s12985-014-0205-0 Text en © Rybicki; licensee BioMed Central Ltd. 2014 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Review
Rybicki, Edward P
Plant-based vaccines against viruses
title Plant-based vaccines against viruses
title_full Plant-based vaccines against viruses
title_fullStr Plant-based vaccines against viruses
title_full_unstemmed Plant-based vaccines against viruses
title_short Plant-based vaccines against viruses
title_sort plant-based vaccines against viruses
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4264547/
https://www.ncbi.nlm.nih.gov/pubmed/25465382
http://dx.doi.org/10.1186/s12985-014-0205-0
work_keys_str_mv AT rybickiedwardp plantbasedvaccinesagainstviruses